Analysts' Opinions Are Mixed on These Healthcare Stocks: 10x Genomics (TXG), Zoetis (ZTS) and Blueprint Medicines (BPMC)
TipRanksMay 1 03:41 ET
Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK), Praxis Precision Medicines (PRAX) and Blueprint Medicines (BPMC)
TipRanksApr 26 06:20 ET
Blueprint Medicines Analyst Ratings
BenzingaApr 26 05:33 ET
Barclays Sticks to Its Hold Rating for Blueprint Medicines (BPMC)
TipRanksApr 26 04:47 ET
Blueprint Medicines: Buy Rating Affirmed on BLU-808 Prospects and Strong Ayvakit Sales Forecast
TipRanksApr 25 20:05 ET
Blueprint Medicines Analyst Ratings
BenzingaApr 10 10:58 ET
Blueprint Medicines Buy Rating: Promising BLU-222 Efficacy and Strong Financial Outlook
TipRanksApr 9 16:25 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch Health Companies (BHC), Blueprint Medicines (BPMC) and Evolent Health (EVH)
TipRanksApr 5 06:40 ET
Blueprint Medicines Analyst Ratings
BenzingaFeb 26 06:51 ET
Buy Rating Affirmed for Blueprint Medicines on Strong Ayvakit Clinical Performance and Promising Pipeline
TipRanksFeb 26 05:55 ET
Analysts Offer Insights on Healthcare Companies: Blueprint Medicines (BPMC), AMN Healthcare Services (AMN) and Ironwood Pharma (IRWD)
TipRanksFeb 26 00:30 ET
Blueprint Medicines: Sell Rating Justified by Gavreto Divestiture and Strategic Shift
TipRanksFeb 25 23:30 ET
Barclays Sticks to Its Hold Rating for Blueprint Medicines (BPMC)
TipRanksFeb 23 03:15 ET
Blueprint Medicines Sell Rating: Assessing Ayvakit's Market Potential and Financial Concerns
TipRanksFeb 18 23:45 ET
Blueprint Medicines Analyst Ratings
BenzingaFeb 16 12:10 ET
Sell Rating on Blueprint Medicines Amidst Concerns Over Long-Term Growth and Financial Outlook
TipRanksFeb 16 07:19 ET
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Blueprint Medicines (BPMC) and Medtronic (MDT)
TipRanksFeb 16 07:01 ET
Analysts Are Bullish on These Healthcare Stocks: Blueprint Medicines (BPMC), Citius Pharmaceuticals (CTXR)
TipRanksFeb 15 14:20 ET
Blueprint Medicines Receives Buy Rating Amid Surpassing Sales and Optimistic Financial Outlook
TipRanksFeb 15 08:05 ET
Blueprint Medicines Analyst Ratings
BenzingaFeb 13 09:10 ET
No Data
No Data